The use of advanced technologies in drug development, the rise in chronic diseases, the growing popularity of personalized medicine, the progression in gene therapy, an aging population, and expanding healthcare needs are some of the factors boosting the long-term growth prospects of the biotech industry.
Therefore, it could be wise to consider buying fundamentally strong biotech stocks Innoviva, Inc. (INVA), Foghorn Therapeutics Inc. (FHTX), and Vertex Pharmaceuticals Incorporated (VRTX).
